Pervaiz Sahir S, D'Adamo Christopher, Mavanur Arun, Wolf Joshua H
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Department of Family and Community Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
J Robot Surg. 2023 Oct;17(5):2205-2209. doi: 10.1007/s11701-023-01642-7. Epub 2023 Jun 5.
Investigations generally assess 30 days of perioperative outcomes with robotic-assisted and laparoscopic colectomy. Outcomes beyond 30 days serve as a quality metric of surgical services and an assessment of 90 days of outcomes may have greater clinical utility. The purpose of this study was to assess 90 days of outcomes, length of stay (LOS), and readmissions among patients who underwent a robotic-assisted versus laparoscopic colectomy using a national database. Patients undergoing either robotic-assisted or laparoscopic colectomy were identified using Current Procedural Terminology (CPT) codes within PearlDiver, a national, inpatient records database from 2010 to 2019. Outcomes were defined using the National Surgical Quality Improvement Program (NSQIP) risk calculator and identified using International Classification of Disease (ICD) diagnosis codes. Categorical variables were compared using chi-square tests, and continuous variables were compared using paired t tests. Covariate-adjusted regression models were also constructed to evaluate these associations while accounting for potential confounders. A total of 82,495 patients were assessed in this study. At 90 days, patients of the laparoscopic colectomy cohort experienced a higher rate of complications than patients who underwent robotic-assisted colectomy (9.5 vs. 6.6%, p < 0.001). There were no significant differences in LOS (6 vs. 6.5 days, p = 0.08) and readmissions (6.1 vs. 6.7%, p = 0.851) at 90 days. Patients undergoing robotic-assisted colectomy have a lower risk for morbidity at 90 days. Neither approach is superior for LOS nor 90 days of readmissions. Both techniques are effective minimally invasive procedures, yet patients may gain a greater risk benefit from robotic colectomy.
研究通常评估机器人辅助结肠切除术和腹腔镜结肠切除术的30天围手术期结局。30天以上的结局作为手术服务的质量指标,评估90天的结局可能具有更大的临床效用。本研究的目的是使用国家数据库评估接受机器人辅助结肠切除术与腹腔镜结肠切除术患者的90天结局、住院时间(LOS)和再入院情况。使用PearlDiver(一个2010年至2019年的全国住院患者记录数据库)中的当前手术操作术语(CPT)代码识别接受机器人辅助或腹腔镜结肠切除术的患者。结局使用国家外科质量改进计划(NSQIP)风险计算器定义,并使用国际疾病分类(ICD)诊断代码识别。分类变量使用卡方检验进行比较,连续变量使用配对t检验进行比较。还构建了协变量调整回归模型,以评估这些关联,同时考虑潜在的混杂因素。本研究共评估了82495名患者。在90天时,腹腔镜结肠切除队列的患者并发症发生率高于接受机器人辅助结肠切除术的患者(9.5%对6.6%,p<0.001)。90天时,住院时间(6天对6.5天,p=0.08)和再入院率(6.1%对6.7%,p=0.851)无显著差异。接受机器人辅助结肠切除术的患者在90天时发病风险较低。两种方法在住院时间和90天再入院率方面均无优势。两种技术都是有效的微创手术,但患者可能从机器人结肠切除术中获得更大的风险益处。